Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 trial evaluating golcadomide in combination with rituximab for newly diagnosed advanced-stage follicular lymphoma, with the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Golcadomide (golcadomide)
  • Rituximab (rituximab)

Snippet

Sponsor: Celgene | Conditions: Lymphoma, Follicular | Phase 2 | Status: ACTIVE_NOT_RECRUITING